AJ11--Synthesis of Cyclic Peptide NPC86
| Location: | Federal |
|---|---|
| Posted: | Jul 23, 2026 |
| Due: | Jul 28, 2026 |
| Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | 36C24826Q0987 |
| Publication URL: | To access bid details, please log in. |
Follow
Active
Contract Opportunity
Notice ID
36C24826Q0987
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
248-NETWORK CONTRACT OFFICE 8 (36C248)
General Information
Classification
Description
Contact Information
History
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Jul 23, 2026 02:04 am EDT
- Original Response Date: Jul 28, 2026 10:00 am EDT
- Inactive Policy: Manual
- Original Inactive Date: Aug 07, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
-
NAICS Code:
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
-
Place of Performance:
Special Notice
Special Notice
Page 4 of 4
Non-GMP Synthesis of NP-C86 (Cyclic Peptide)
James A. Haley VA Medical Center, 13000 Bruce B. Downs Blvd., Tampa, Florida 33612, intends to solicit sole source to Curia Global Inc., for the NPC86 which is a new drug designed to alleviate metabolic diseases such as T2D and neurodegenerative diseases. The chemistry to synthesize the drug is highly specialized and uses the solid state synthesis method. The target is to synthesize 2 grams of NPC86 which is acyclic peptide.
Curia will use Solid Phase Peptide Synthesis (SPPS) for this peptide, initiating the synthesis on Rink amide resin. This approach will yield an amide functionality at the C-terminal upon cleavage. The target specification for the final compound is 95% purity by HPLC (area%, non-validated).
Period of performance is 8/17/2026 to 8/16/2027. The North American Industry Classification System (NAICS) code is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Any information regarding this requirement must be received no later than 7/28/2026 @ 10:00 AM EST. Please provide a letter from the manufacturer stating authorization to work with Curia Global Inc.
DISCLAIMER
This request for information is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this request for information that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.
Special Notice
Page 4 of 4
Non-GMP Synthesis of NP-C86 (Cyclic Peptide)
James A. Haley VA Medical Center, 13000 Bruce B. Downs Blvd., Tampa, Florida 33612, intends to solicit sole source to Curia Global Inc., for the NPC86 which is a new drug designed to alleviate metabolic diseases such as T2D and neurodegenerative diseases. The chemistry to synthesize the drug is highly specialized and uses the solid state synthesis method. The target is to synthesize 2 grams of NPC86 which is acyclic peptide.
Curia will use Solid Phase Peptide Synthesis (SPPS) for this peptide, initiating the synthesis on Rink amide resin. This approach will yield an amide functionality at the C-terminal upon cleavage. The target specification for the final compound is 95% purity by HPLC (area%, non-validated).
Period of performance is 8/17/2026 to 8/16/2027. The North American Industry Classification System (NAICS) code is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Any information regarding this requirement must be received no later than 7/28/2026 @ 10:00 AM EST. Please provide a letter from the manufacturer stating authorization to work with Curia Global Inc.
DISCLAIMER
This request for information is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this request for information that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.
Attachments/Links
Contracting Office Address
- 8875 HIDDEN RIVER PARKWAY
- TAMPA , FL 33637
- USA
Primary Point of Contact
- Keila President
- keila.president@va.gov
- Phone Number N/A
Secondary Point of Contact
- Jul 23, 2026 02:04 am EDTSpecial Notice (Original)
Daily notification on new contract opportunities
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
...Follow N33191-26-R-0023 Design-Build Counter Narcotics Law Enforcement National Drug Law...-Build Counter Narcotics Law ...
DEPT OF DEFENSE
Bid Due: 7/31/2026
...Follow N33191-26-R-0023 Design-Build Counter Narcotics Law Enforcement National Drug Law... Enforcement National Drug ...
DEPT OF DEFENSE
Bid Due: 7/31/2026
...HUMAN SERVICES, DEPARTMENT OF Sub-tier FOOD AND DRUG ADMINISTRATION Office FDA OFFICE OF ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 7/31/2026
.../Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier FOOD AND DRUG ADMINISTRATION ...
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 8/07/2026
* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.